Indivior PLC Ordinary Shares
Price & Volume
Stats
See more52W Range | $10.63-$40.02 |
Market Cap | $4.4B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $1.2B |
Revenue Growth (YoY) | 19.2% |
Gross Profit (12 Mos) | $1B |
Diluted EPS | $1.95 |
News
See moreYahoo Finance • 2 days ago
Indivior Q1 Earnings Call Highlights
Yahoo Finance • 8 days ago
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
Yahoo Finance • 2 months ago
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
Yahoo Finance • 2 months ago
Mid-Cap healthcare stocks ranked by quant ratings after earnings season
About
CEO | Mr. Joseph J. Ciaffoni |
Address | 10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 827 |